US Stock MarketDetailed Quotes

CORT Corcept Therapeutics

Watchlist
  • 34.570
  • +0.690+2.04%
Close Jul 22 16:00 ET
3.60BMarket Cap32.92P/E (TTM)

Corcept Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
38.95%146.81M
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
5.82%101.73M
12.88%103.39M
Operating revenue
38.95%146.81M
20.04%482.38M
31.39%135.41M
21.50%123.6M
13.86%117.72M
12.77%105.65M
9.80%401.86M
4.28%103.06M
5.82%101.73M
12.88%103.39M
Cost of revenue
82.90%2.54M
20.35%6.48M
26.82%1.88M
22.85%1.65M
19.60%1.57M
10.88%1.39M
1.97%5.39M
9.31%1.48M
5.02%1.34M
-4.91%1.32M
Gross profit
38.37%144.27M
20.03%475.89M
31.46%133.53M
21.48%121.96M
13.79%116.14M
12.80%104.27M
9.92%396.47M
4.21%101.58M
5.83%100.39M
13.15%102.07M
Operating expense
28.36%114.77M
29.87%368.61M
28.81%101.86M
32.61%90.78M
22.54%86.56M
36.16%89.42M
20.16%283.84M
30.05%79.08M
16.77%68.46M
21.24%70.64M
Selling and administrative expenses
15.86%56.27M
20.55%184.26M
11.41%47.15M
28.72%45.26M
14.46%43.28M
29.34%48.56M
24.92%152.85M
31.09%42.32M
15.16%35.16M
25.92%37.81M
Research and development costs
43.22%58.51M
40.74%184.35M
48.85%54.71M
36.72%45.52M
31.84%43.28M
45.27%40.85M
15.04%130.99M
28.88%36.75M
18.51%33.29M
16.27%32.83M
Operating profit
98.61%29.5M
-4.75%107.28M
40.76%31.67M
-2.37%31.18M
-5.88%29.58M
-44.51%14.85M
-9.51%112.63M
-38.63%22.5M
-11.86%31.93M
-1.60%31.43M
Net non-operating interest income expense
53.39%5.49M
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
1,386.11%1.07M
472.73%630K
Non-operating interest income
53.39%5.49M
385.66%17.28M
189.25%5.14M
386.73%5.21M
431.27%3.35M
4,376.25%3.58M
572.40%3.56M
2,368.06%1.78M
1,386.11%1.07M
472.73%630K
Other net income (expense)
Special income (charges)
----
--0
----
----
----
----
--0
----
----
----
Income before tax
89.83%34.99M
7.20%124.56M
51.63%36.81M
10.24%36.39M
2.71%32.93M
-31.34%18.43M
-7.05%116.19M
-33.92%24.28M
-9.09%33M
0.03%32.06M
Income tax
183.01%7.23M
24.67%18.42M
-28.94%5.45M
412.16%5.01M
16.17%5.4M
-36.94%2.56M
18.24%14.77M
63.89%7.68M
-127.50%-1.6M
-15.91%4.65M
Net income
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
Net income continuous Operations
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
Minority interest income
Net income attributable to the parent company
74.83%27.76M
4.66%106.14M
88.87%31.36M
-9.33%31.38M
0.42%27.53M
-30.35%15.88M
-9.86%101.42M
-48.21%16.6M
13.58%34.61M
3.35%27.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.06%27.51M
4.15%105.5M
88.37%31.14M
-9.78%31.17M
-0.15%27.36M
-30.66%15.81M
-9.98%101.29M
-48.42%16.53M
13.39%34.55M
3.30%27.4M
Basic earnings per share
80.00%0.27
7.37%1.02
100.00%0.3
-3.13%0.31
3.85%0.27
-31.82%0.15
-2.06%0.95
-46.43%0.15
23.08%0.32
13.04%0.26
Diluted earnings per share
78.57%0.25
8.05%0.94
100.00%0.28
-6.67%0.28
4.17%0.25
-30.00%0.14
-2.25%0.87
-46.15%0.14
25.00%0.3
14.29%0.24
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 38.95%146.81M20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M5.82%101.73M12.88%103.39M
Operating revenue 38.95%146.81M20.04%482.38M31.39%135.41M21.50%123.6M13.86%117.72M12.77%105.65M9.80%401.86M4.28%103.06M5.82%101.73M12.88%103.39M
Cost of revenue 82.90%2.54M20.35%6.48M26.82%1.88M22.85%1.65M19.60%1.57M10.88%1.39M1.97%5.39M9.31%1.48M5.02%1.34M-4.91%1.32M
Gross profit 38.37%144.27M20.03%475.89M31.46%133.53M21.48%121.96M13.79%116.14M12.80%104.27M9.92%396.47M4.21%101.58M5.83%100.39M13.15%102.07M
Operating expense 28.36%114.77M29.87%368.61M28.81%101.86M32.61%90.78M22.54%86.56M36.16%89.42M20.16%283.84M30.05%79.08M16.77%68.46M21.24%70.64M
Selling and administrative expenses 15.86%56.27M20.55%184.26M11.41%47.15M28.72%45.26M14.46%43.28M29.34%48.56M24.92%152.85M31.09%42.32M15.16%35.16M25.92%37.81M
Research and development costs 43.22%58.51M40.74%184.35M48.85%54.71M36.72%45.52M31.84%43.28M45.27%40.85M15.04%130.99M28.88%36.75M18.51%33.29M16.27%32.83M
Operating profit 98.61%29.5M-4.75%107.28M40.76%31.67M-2.37%31.18M-5.88%29.58M-44.51%14.85M-9.51%112.63M-38.63%22.5M-11.86%31.93M-1.60%31.43M
Net non-operating interest income expense 53.39%5.49M385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M1,386.11%1.07M472.73%630K
Non-operating interest income 53.39%5.49M385.66%17.28M189.25%5.14M386.73%5.21M431.27%3.35M4,376.25%3.58M572.40%3.56M2,368.06%1.78M1,386.11%1.07M472.73%630K
Other net income (expense)
Special income (charges) ------0------------------0------------
Income before tax 89.83%34.99M7.20%124.56M51.63%36.81M10.24%36.39M2.71%32.93M-31.34%18.43M-7.05%116.19M-33.92%24.28M-9.09%33M0.03%32.06M
Income tax 183.01%7.23M24.67%18.42M-28.94%5.45M412.16%5.01M16.17%5.4M-36.94%2.56M18.24%14.77M63.89%7.68M-127.50%-1.6M-15.91%4.65M
Net income 74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M
Net income continuous Operations 74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M
Minority interest income
Net income attributable to the parent company 74.83%27.76M4.66%106.14M88.87%31.36M-9.33%31.38M0.42%27.53M-30.35%15.88M-9.86%101.42M-48.21%16.6M13.58%34.61M3.35%27.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.06%27.51M4.15%105.5M88.37%31.14M-9.78%31.17M-0.15%27.36M-30.66%15.81M-9.98%101.29M-48.42%16.53M13.39%34.55M3.30%27.4M
Basic earnings per share 80.00%0.277.37%1.02100.00%0.3-3.13%0.313.85%0.27-31.82%0.15-2.06%0.95-46.43%0.1523.08%0.3213.04%0.26
Diluted earnings per share 78.57%0.258.05%0.94100.00%0.28-6.67%0.284.17%0.25-30.00%0.14-2.25%0.87-46.15%0.1425.00%0.314.29%0.24
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg